MA S1915 | 2021-2022 | 192nd General Court

Note: Legislation replaced by H5250

Status

Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on March 29 2021 - 25% progression, died in chamber
Action: 2022-10-03 - Accompanied a study order, see H5250
Text: Latest bill text (Introduced) [PDF]

Summary

For legislation to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing. Revenue.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

To eliminate the tax deduction for direct-to-consumer pharmaceutical marketing

Sponsors


History

DateChamberAction
2022-10-03HouseAccompanied a study order, see H5250
2021-12-14JointHearing scheduled for 12/22/2021 from 10:00 AM-05:00 PM in Virtual Hearing
2021-03-29HouseHouse concurred
2021-03-29SenateReferred to the Joint Committee on Revenue

Same As/Similar To

S1981 (Similar To) 2022-10-03 - Accompanied a study order, see H5250
S1929 (Similar To) 2022-09-22 - Accompanied a study order, see H4894
S1811 (Similar To) 2022-09-26 - Accompanied a study order, see H5247
H5250 (Replaced by) 2023-01-03 - No further action taken
S1858 (Similar To) 2022-09-22 - Accompanied a study order, see H4894

Massachusetts State Sources


Bill Comments

feedback